| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 602.10M | 561.30M | 586.50M | 622.20M | 594.30M |
| Gross Profit | 250.60M | 249.70M | 245.80M | 247.60M | 239.00M |
| EBITDA | 122.60M | 107.20M | 102.00M | 92.00M | 104.20M |
| Net Income | 45.20M | 33.50M | 38.50M | 36.50M | 41.00M |
Balance Sheet | |||||
| Total Assets | 1.10B | 993.00M | 978.80M | 1.03B | 1.03B |
| Cash, Cash Equivalents and Short-Term Investments | 44.80M | 43.60M | 17.00M | 50.00M | 52.30M |
| Total Debt | 252.90M | 172.80M | 166.30M | 216.20M | 218.00M |
| Total Liabilities | 438.70M | 350.00M | 342.20M | 401.10M | 408.30M |
| Stockholders Equity | 662.90M | 643.00M | 636.60M | 627.10M | 617.70M |
Cash Flow | |||||
| Free Cash Flow | 65.80M | 79.50M | 63.10M | 43.10M | 40.30M |
| Operating Cash Flow | 93.40M | 105.10M | 97.60M | 86.90M | 74.90M |
| Investing Cash Flow | -133.20M | -27.90M | -28.50M | -44.00M | -270.50M |
| Financing Cash Flow | 40.90M | -50.60M | -102.10M | -45.20M | 203.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.12B | 11.05 | 18.46% | 1.68% | 20.57% | -3.18% | |
74 Outperform | £244.66M | 117.95 | 6.14% | 3.48% | -3.93% | 41.83% | |
70 Neutral | £499.35M | 16.44 | 22.71% | 5.91% | -4.70% | -2.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £107.42M | 13.69 | 9.23% | 3.97% | 5.51% | -33.75% | |
60 Neutral | £718.02M | 18.00 | 7.59% | 3.19% | 5.88% | 107.36% | |
57 Neutral | £154.10M | 212.00 | 1.61% | 4.39% | -3.51% | -67.38% |